Atripla

In the US, Atripla (efavirenz/emtricitabine/tenofovir systemic) is a member of the drug class antiviral combinations and is used to treat HIV Infection.

US matches:

• Atripla

UK matches:

• Atripla 600 mg/200 mg/245 mg film coated tablets (SPC)

Ingredient matches for Atripla

Efavirenz

Efavirenz is reported as an ingredient of Atripla in the following countries:

• Australia


• Austria


• Denmark


• France


• Germany


• Norway


• Sweden


• Switzerland


• United Kingdom


• United States

Emtricitabine

Emtricitabine is reported as an ingredient of Atripla in the following countries:

• Australia


• Austria


• Denmark


• France


• Germany


• Norway


• Sweden


• Switzerland


• United Kingdom


• United States

Tenofovir

Tenofovir is reported as an ingredient of Atripla in the following countries:

• Australia

Tenofovir disoproxil fumarate (a derivative of Tenofovir) is reported as an ingredient of Atripla in the following countries:

• Austria


• Denmark


• France


• Germany


• Norway


• Sweden


• Switzerland


• United Kingdom


• United States

Tipranavir

Tipranavir is reported as an ingredient of Atripla in the following countries:

• Ireland

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.